James Sullivan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Medical Education, Goldsboro, NC 27534 Phone: 919-736-1110 Fax: 315-624-6469 |
Adil Ahmed, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Goldsboro, NC 27534 Phone: 919-736-1110 |
Jason K Boyd, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 203 Cox Blvd, Goldsboro, NC 27534 Phone: 919-580-0000 Fax: 919-587-9047 |
Dr. Akanksha Singh Kashyap, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 208 Cox Blvd Ste 102, Goldsboro, NC 27534 Phone: 919-731-6018 Fax: 919-580-7010 |
Siva Santosh Kumar Santosh Kumar Gandu, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 2700 Wayne Memorial Dr, Goldsboro, NC 27534 Phone: 919-587-4394 |
Jodel Giraud, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Goldsboro, NC 27534 Phone: 919-731-6407 |
News Archive
The preliminary results of a Universit- de Montr-al study show that fathers of sexually abused children can suffer from anxiety, depression and grief. Such patriarchs are often overwhelmed by a desire for vengeance, yet little literature exists to help them deal with their pain.
BioSante Pharmaceuticals, Inc., today announced it sold to Cold Genesys, Inc. exclusive, worldwide rights to develop and commercialize its oncolytic virus technology. The technology includes CG0070, a replication-competent adenovirus that has completed a Phase I clinical trial for treatment of superficial bladder cancer. In exchange for the technology, BioSante received a 19.9 percent ownership position in Cold Genesys and a $95,000 upfront cash payment and is eligible to receive future milestone and royalty payments.
Statement by Wyeth Pharmaceuticals supporting the U.S. Food and Drug Administration (FDA) Joint Advisory Committee's recommendation to strengthen the product labels across the antidepressant category regarding use in the pediatric population.
The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes, according to researchers.
› Verified 9 days ago